
Orthofix International (OFIX) Stock Forecast & Price Target
Orthofix International (OFIX) Analyst Ratings
Bulls say
Orthofix Medical is showing signs of growth, especially within their Global Spine segment, as well as strong cash flow and a solid balance sheet. However, the current distributor transition and potential legal settlement may have impacted short-term performance. With new product launches and a promising pipeline, the company has potential for long-term success but may face some near-term challenges.
Bears say
Orthofix Medical is currently experiencing difficulties with their adjusted EBITDA margin and weaker demand for their Global Limb Reconstruction segment. The recent pushback of their longer-term adjusted EBITDA margin target from 2027 to 2028 also indicates potential challenges ahead. This, paired with lower guidance for FY/26 and disappointing results in comparison to our estimates warrants a negative outlook on the stock.
This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.
Orthofix International (OFIX) Analyst Forecast & Price Prediction
Start investing in Orthofix International (OFIX)
Order type
Buy in
Order amount
Est. shares
0 shares